help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, S.
Right arrow Articles by Woda, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, S.
Right arrow Articles by Woda, B. A.
(American Journal of Pathology. 1999;155:247-255.)
© 1999 American Society for Investigative Pathology


Regular Articles

Expression of the Eukaryotic Translation Initiation Factors 4E and 2{alpha} in Non-Hodgkin's Lymphomas

Songtao Wang*, Igor B. Rosenwald*{dagger}, Michael J. Hutzler*, German A. Pihan*, Lou Savas*, Jane-Jane Chen{dagger} and Bruce A. Woda*

From the Department of Pathology,*
University of Massachusetts Medical School, Worcester, and Department of Health Sciences and Technology,{dagger}
Harvard University-Massachusetts Institute of Technology, Cambridge, Massachusetts

Transition of cells from quiescence to proliferation requires an increase in the rate of protein synthesis, which is regulated in part by two key translation initiation factors, 4E and 2{alpha}. The expression and activity of both factors are increased transiently when normal resting cells are stimulated to proliferate. They are constitutively elevated in oncogene transformed cultured cells, and overexpression of either initiation factor in rodent cells makes them tumorigenic. In this study we investigate an association between the expression of translation initiation factors and lymphomagenesis. We have analyzed the expression of the protein synthesis initiation factors 4E and 2{alpha} by immunohistochemistry in reactive lymph nodes and several types of non-Hodgkin's lymphoma representing a wide range of clinical behaviors based on the Revised European-American Lymphoma behavioral classification. The study included 7 benign lymph nodes with follicular hyperplasia, 26 indolent lymphomas (6 marginal zone lymphomas, 7 small lymphocytic lymphomas, and 13 follicular lymphomas, grades 1 and 2), 16 moderately aggressive lymphomas (8 mantle cell lymphomas and 8 follicular lymphomas, grade 3), 24 aggressive lymphomas (14 large-B-cell lymphomas and 10 anaplastic large-cell lymphomas), and 15 highly aggressive lymphomas (7 lymphoblastic lymphomas and 8 Burkitt's lymphomas). Strong expression of initiation factors 4E and 2{alpha} was demonstrated in the germinal centers of reactive follicles. Minimal or no expression was seen in the mantle zones and surrounding paracortices, indicating that high expression of initiation factors 4E and 2{alpha} is associated with the active proliferation of lymphocytes. Most cases of aggressive and highly aggressive lymphomas showed strong expression of initiation factors 4E and 2{alpha}, in contrast to the cases of indolent and moderately aggressive lymphoma, in which their expression was intermediate between the germinal centers and the mantles of reactive follicles. A positive correlation was found between the expression of both initiation factors 4E and 2{alpha} and the Revised European-American Lymphoma behavior classification (P < 0.05). Thus, constitutively increased expression of initiation factors 4E and 2{alpha} may play an important role in the development of lymphomas and is correlated with their biological aggressiveness.





This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
E. Peponi, E. Drakos, G. Reyes, V. Leventaki, G. Z. Rassidakis, and L. J. Medeiros
Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma
Am. J. Pathol., December 1, 2006; 169(6): 2171 - 2180.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Vega, L. J. Medeiros, V. Leventaki, C. Atwell, J. H. Cho-Vega, L. Tian, F.-X. Claret, and G. Z. Rassidakis
Activation of Mammalian Target of Rapamycin Signaling Pathway Contributes to Tumor Cell Survival in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma.
Cancer Res., July 1, 2006; 66(13): 6589 - 6597.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Othumpangat, M. Kashon, and P. Joseph
Eukaryotic Translation Initiation Factor 4E Is a Cellular Target for Toxicity and Death Due to Exposure to Cadmium Chloride
J. Biol. Chem., July 1, 2005; 280(26): 25162 - 25169.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Topisirovic, A. Kentsis, J. M. Perez, M. L. Guzman, C. T. Jordan, and K. L. B. Borden
Eukaryotic Translation Initiation Factor 4E Activity Is Modulated by HOXA9 at Multiple Levels
Mol. Cell. Biol., February 1, 2005; 25(3): 1100 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Kentsis, I. Topisirovic, B. Culjkovic, L. Shao, and K. L. B. Borden
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
PNAS, December 28, 2004; 101(52): 18105 - 18110.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Topisirovic, M. L. Guzman, M. J. McConnell, J. D. Licht, B. Culjkovic, S. J. Neering, C. T. Jordan, and K. L. B. Borden
Aberrant Eukaryotic Translation Initiation Factor 4E-Dependent mRNA Transport Impedes Hematopoietic Differentiation and Contributes to Leukemogenesis
Mol. Cell. Biol., December 15, 2003; 23(24): 8992 - 9002.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Singhal, R. Wiewrodt, L. D. Malden, K. M. Amin, K. Matzie, J. Friedberg, J. C. Kucharczuk, L. A. Litzky, S. W. Johnson, L. R. Kaiser, et al.
Gene Expression Profiling of Malignant Mesothelioma
Clin. Cancer Res., August 1, 2003; 9(8): 3080 - 3097.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Durig, H. Nuckel, A. Huttmann, E. Kruse, T. Holter, K. Halfmeyer, A. Fuhrer, R. Rudolph, N. Kalhori, A. Nusch, et al.
Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia
Blood, April 1, 2003; 101(7): 2748 - 2755.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Topisirovic, A. D. Capili, and K. L. B. Borden
Gamma Interferon and Cadmium Treatments Modulate Eukaryotic Initiation Factor 4E-Dependent mRNA Transport of Cyclin D1 in a PML-Dependent Manner
Mol. Cell. Biol., September 1, 2002; 22(17): 6183 - 6198.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
F. Meric and K. K. Hunt
Translation Initiation in Cancer: A Novel Target for Therapy
Mol. Cancer Ther., September 1, 2002; 1(11): 971 - 979.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.